The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage ...

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide ...

Medicare coverage of a new osteoporosis screening tool may help to address the challenge of identifying and treating patients ...

Annals of Internal Medicine publishes study showing potential benefits of Stockholm3 in identifying patients with aggressive prostate cancerSTOCKHOLM, June 22, 2026 (GLOBE NEWSWIRE) -- A3P Biomedical, ...

New research among lung cancer screening participants has found that low-dose chest computed tomography (CT) screening is ...

Using AI on mammograms can identify patients at highest risk for breast cancer and get them same-day follow up care, eliminating stressful waiting times.

A new test could be more effective at detecting dangerous prostate cancer than current screening methods, a study suggests.

Background Sideline detection is the first and most significant step in recognising a potential concussion and removing an athlete from harm. This systematic review aims to evaluate the critical ...

Traditional malnutrition screening instruments, including the Malnutrition Universal Screening Tool (MUST), strongly rely on low body mass index (BMI) and weight loss. In overweight/obese patients, ...